RCL — Royal Caribbean Cruises Ltd.

Sell-side sentiment is constructive: consensus is Buy with a ~$348 average price target, and Q2 2026 adjusted EPS of $4.21 beat the $3.98 consensus while FY2026 EPS guidance was raised to $17.73-$17.87. The price action as of 2026-08-27 is risk-off, but the underlying tone from analysts and the booking/demand narrative remains bullish.

Revenue growth is decelerating but still healthy: Q2 revenue went from $4.11B in 2024 to $4.54B in 2025 to $4.83B in 2026 (+6.5% YoY). Q2 2026 operating income of $1.31B and net income of $1.13B were slightly below year-ago levels, so operating margin compressed to ~27% from ~29%; this reflects fuel cost, itinerary disruption, and a tough comparison, not demand collapse. TTM operating margin is 27.3%, net margin 23.6%, and first-half 2026 EPS rose ~8% YoY. Q3 is the seasonal peak (Q3 2025 EPS was $5.74), and management guided Q3 2026 EPS to $6.26-$6.36, so the trend is moderating growth on top of record profitability.

As of 2026-08-27, RCL trades at 17.5x trailing EPS and ~16.0x FY2026 consensus EPS, below its available historical average P/E of ~19.4x; P/S of 4.09x is also below the 4.86x average. The trailing PEG is 0.82, but on forward growth of ~14% the forward PEG is ~1.1, so the stock is modestly cheaper than its own history, not a deep-value bargain. The average analyst target of $348.09 is ~22% above the price.

At $284.80, the market is paying only ~16x guided FY2026 EPS. That is not pricing in aggressive growth; it is pricing in execution risk from leverage, fuel costs, and itinerary disruption. If RCL delivers its raised guidance, the stock is likely undervalued; if the consumer or geopolitical backdrop deteriorates, the multiple has room to fall despite the cheap-looking historical P/E. In short, the stock is in show-me mode after a ~22% drawdown from its high.

As of 2026-08-27, RSI stood at 35.71, weak but not yet oversold. Price was 6.87% below its 20-day SMA, 5.89% below its 50-day SMA, and only 0.95% below its 200-day SMA, so the short-term trend is down while the long-term trend is barely being tested. A patient entry would wait for RSI stabilization and a reclaim of the 20/50-day MAs; a clean loss of the 200-day would open a test of the $232 area.

• High beta (1.78) makes RCL disproportionately sensitive to rising bond yields and risk-off rotations in consumer cyclicals.
• Elevated oil/fuel prices and Middle East geopolitical tension are pressuring costs and causing itinerary shifts.
• Consumer spending is rotating toward experiences, a tailwind, but a macro slowdown would hit discretionary travel first.
• High leverage (D/E 2.30, ~3.2x net debt/EBITDA) leaves earnings and refinancing vulnerable to higher-for-longer rates.
• Lumpy newbuild capex (e.g., Legend of the Seas, Star of the Seas) creates negative FCF quarters even when the business is healthy.

• Q3 2026 earnings — management guided EPS of $6.26-$6.36; actual results and booking commentary will set the tone.
• Sustained close-in booking demand and net yield expansion (modeled 1.75%-2.25%) into peak season.
• New ship deliveries and fleet/deployment updates, including Star of the Seas and Celebrity Xcel, supporting future yield growth.
• Further deleveraging or favorable refinancing after the $1.25B debt optimization.

• Macro/consumer downturn — high-beta discretionary travel is among the first budgets cut in a recession.
• Geopolitical escalation in the Middle East/Mediterranean causing more itinerary disruptions and safety concerns.
• Fuel price spikes compressing margins if not offset by surcharges or hedges.
• Balance-sheet strain: current ratio of 0.21, D/E of 2.30, and negative trailing FCF limit financial flexibility.
• Execution risk on a heavy newbuild pipeline if demand softens before ships are delivered.

RCL is executing well operationally — Q2 beat, FY guide raised, TTM operating margin near 27%, and negative accruals signal real cash earnings. The problem is the balance sheet and the macro setup: high leverage, a very low current ratio, and lumpy negative FCF make the stock vulnerable to a consumer or geopolitical shock. I see a valuation cushion, but not enough to override the weak financial-health read, so my lean is cautious.

Applied an 18.5x forward P/E to FY2026 consensus EPS of $17.779, a discount to RCL's ~19.4x historical average P/E to reflect high leverage and macro/geopolitical risk but a premium to the current ~16x forward multiple to reflect raised guidance, high margins, and negative accruals (healthy cash conversion). This yields $328.91.